Search

Your search keyword '"Billups, Rocky"' showing total 34 results

Search Constraints

Start Over You searched for: Author "Billups, Rocky" Remove constraint Author: "Billups, Rocky"
34 results on '"Billups, Rocky"'

Search Results

2. Outpatient Administration of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy for Non-Hodgkin Lymphoma (NHL), in a Large Multi-Center Network

3. Carvykti (cilta-cel) Real World Outcomes across the Sarah Cannon Transplant Cell Therapy Network

4. A Standardized Cell Dose to Optimize Unrelated Donor Peripheral Blood Stem Cell (PBSC) Collections: A Prospective Study between the Sarah Cannon Transplant and Cellular Therapy Network (SCTCTN) and the National Marrow Donor Program (NMDP)

5. Centralized Data Management Model within the Sarah Cannon Transplant and Cellular Therapy Network (SCTCTN)- Process, Challenges and Benefits

7. Remote Patient Monitoring (RPM) Technology with Centralized Virtual Nurse Monitoring for Safe Delivery of Outpatient Chimeric Antigen Receptor T-Cell (CAR-T) Therapy across Multiple Sarah Cannon Transplant and Cellular Therapy Network Programs

8. Outcomes for Anti-CD19+ Chimeric Antigen Receptor T (CAR-T) Cell Therapy for Non Hodgkin Lymphoma (NHL) across a Large Community Transplant and Cellular Therapy Network

9. Access Barriers for Anti-CD19+ Chimeric Antigen Receptor T (CAR-T) Cell Therapy for Non-Hodgkin Lymphoma (NHL) across a Large Community Transplant and Cellular Therapy Network

10. Standardization of Outpatient Care after CAR-T Therapy across a Large Cell Therapy Network- through Technology and Decentralized Virtual Nurses: Preliminary Results

11. Successful Virtual Mock FACT Inspection: How Sarah Cannon Blood Cancer Network and Texas Transplant Institute in San Antonio and Austin Made It Work

12. 273 - Outcomes for Anti-CD19+ Chimeric Antigen Receptor T (CAR-T) Cell Therapy for Non Hodgkin Lymphoma (NHL) across a Large Community Transplant and Cellular Therapy Network

13. 64 - Access Barriers for Anti-CD19+ Chimeric Antigen Receptor T (CAR-T) Cell Therapy for Non-Hodgkin Lymphoma (NHL) across a Large Community Transplant and Cellular Therapy Network

14. Reduction in Transplantation Activity without Impairment in Outcomes in the Covid-19 Era- Data from the Sarah Cannon Blood Cancer Network (SCBCN)

21. Deployment of an Electronic HCT Workflow Application Allows for Comprehensive Management of Recipients, Donors, and HPC Products

25. Access Barriers to Anti-CD19+ CART-Cell Therapy for NHL Across a Community Transplant and Cellular Therapy Network

Catalog

Books, media, physical & digital resources